Log In
BCIQ
Print this Print this
 

ropinirole (AZ-009)

  Manage Alerts
Collapse Summary General Information
Company Grupo Ferrer Internacional S.A.
DescriptionRopinirole delivered by Staccato system inhaler
Molecular Target Dopamine receptor
Mechanism of ActionDopamine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat hypomobility in Parkinson's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$54.6M

$19.6M

$35.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/21/2016

$54.6M

$19.6M

$35.0M

Get a free BioCentury trial today